The 10 that are cited most themselves, of 57.
Judgment of the General Court (Ninth Chamber) of 8 September 2016. H. Lundbeck A/S and Lundbeck Ltd v European Commission.Decision
… на разследване във фармацевтичния сектор в съответствие с член 17 от Регламент № 1/2003 (преписка COMP/D2/39514). В член единствен от това …
8 Sep 2016 · 62013TJ0472
Arrêt du Tribunal (neuvième chambre) du 8 septembre 2016. Xellia Pharmaceuticals ApS et Alpharma LLC, anciennement Zoetis Products LLC contrDecision
… 15 January 2008, the Commission adopted the decision initiating an inquiry into the pharmaceutical sector, pursuant to Article 17 of Regulation No 1/2003 (Case No COMP/D2/39514). The single article of that decision stated that the inquiry …
8 Sep 2016 · 62013TJ0471
Arrêt du Tribunal (neuvième chambre) du 8 septembre 2016. Sun Pharmaceuticals Industries Ltd, anciennement Ranbaxy Laboratories Ltd et RanbaDecision
… 15 January 2008, the Commission adopted the decision initiating an inquiry into the pharmaceutical sector pursuant to Article 17 of Regulation No 1/2003 (Case No COMP/D2/39514). The single article of that decision stated that the inquiry …
8 Sep 2016 · 62013TJ0460
Arrêt du Tribunal (neuvième chambre) du 8 septembre 2016. Generics (UK) Ltd contre Commission européenne.Decision
… 15 January 2008, the Commission adopted the decision initiating an inquiry into the pharmaceutical sector pursuant to Article 17 of Regulation No 1/2003 (Case No COMP/D2/39514). The single article of that decision stated that the inquiry …
8 Sep 2016 · 62013TJ0469
Arrêt du Tribunal (neuvième chambre) du 8 septembre 2016. Merck KGaA contre Commission européenne.Decision
… 15 January 2008, the Commission adopted the decision initiating an inquiry into the pharmaceutical sector pursuant to Article 17 of Regulation No 1/2003 (Case No COMP/D2/39514). The single article of that decision stated that the inquiry …
8 Sep 2016 · 62013TJ0470
Arrêt du Tribunal (neuvième chambre) du 8 septembre 2016. Arrow Group ApS et Arrow Generics Ltd contre Commission européenne.Decision
… 15 January 2008, the Commission adopted the decision initiating an inquiry into the pharmaceutical sector pursuant to Article 17 of Regulation No 1/2003 (Case No COMP/D2/39514). The single article of that decision stated that the inquiry …
8 Sep 2016 · 62013TJ0467
Judgment of the Court (Fourth Chamber) of 25 March 2021. H. Lundbeck A/S and Lundbeck Ltd v European Commission.Decision
… januar 2008 beslutningen om iværksættelse af en undersøgelse vedrørende lægemiddelsektoren i henhold til artikel 17 i forordning nr. 1/2003 (sag COMP/D2/39514). Det præciseredes i den eneste artikel i denne beslutning, at den …
25 Mar 2021 · 62016CJ0591
Judgment of the General Court (Ninth Chamber, Extended Composition) of 12 December 2018 (Extracts). Servier SAS and Others v European CommisDecision
On 15 January 2008, the Commission of the European Communities decided to open an inquiry into the pharmaceutical sector pursuant to Article 17 of Council Regulation (EC) No 1/2003 of 16 December 2002 on the implementation of the rules on …
12 Dec 2018 · 62014TJ0691
Judgment of the Court (Fourth Chamber) of 25 March 2021. Xellia Pharmaceuticals ApS and Alpharma, LLC, anciennement Zoetis Products LLC v EuDecision
The initiation, on 15 January 2008, of a sector inquiry on the basis of Article 17 of Regulation No 1/2003 the objective of which is, as is apparent, in essence, from paragraph 22 of the judgment under appeal, recital 12 of the decision at …
25 Mar 2021 · 62016CJ0611
Judgment of the Court (Fourth Chamber) of 25 March 2021. Arrow Group ApS and Arrow Generics Ltd v European Commission.Decision
… 15 January 2008, the Commission adopted the decision initiating an inquiry into the pharmaceutical sector pursuant to Article 17 of Regulation No 1/2003 (Case No COMP/D2/39514). The single article of that decision stated that the inquiry …
25 Mar 2021 · 62016CJ0601